$10 Billion Research Boost for Long COVID Treatments and Affordable Care
This Act allocates $10 billion over ten years to accelerate research into the causes, prevention, and treatment of Long COVID and related chronic conditions. It establishes a dedicated research program at the NIH and mandates the creation of specialized clinics and improved provider training to ensure better diagnosis and coordinated care for citizens. A critical provision requires that drugs developed using these federal funds must be sold at fair and reasonable prices, capped by international standards.
Key points
Massive Research Funding: $1 billion annually for 10 years dedicated to intensive research on Long COVID, including pediatric patients and comparison with similar chronic illnesses.
Drug Price Control: Medications and devices developed with federal funding must be reasonably priced and cannot exceed the lowest price charged in six major developed countries (e.g., Canada, UK).
Improved Healthcare Access: Establishment of specialized clinics and training programs for healthcare providers to enhance the quality of care and diagnosis for Long COVID patients.
Patient Involvement: Patients and caregivers are guaranteed representation on the new Advisory Board to directly influence research priorities and funding decisions.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.